AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting risk

DH · NASDAQ · Medical - Healthcare Information Services

Definitive Healthcare

Combines healthcare data and workflow tools for commercial teams.

$0.8200

After-hours close+0.02 (+2.21%)

At close$0.8023(−1.49%)

Something off on this page? Send us feedback.

Profile

Definitive Healthcare Corp.DHHealth Care

Subscriptions combine provider, claims, expert, and workflow data for life-sciences, provider, and diversified customers. Products support healthcare research, targeting, affiliations, claims analysis, and sales execution.

Subscriptions bring together healthcare organization, professional, claims, affiliation, and scientific-expert data with workflow tools for customers selling into or operating across healthcare. Customers include life-sciences companies, care providers, and diversified organizations such as healthcare IT and staffing firms.

Reference & Affiliations: View supplies organization, professional, claims, and affiliation intelligence. Medical & Scientific Experts: Monocl focuses on experts, while Claims & Consumer Analytics: Populi supports physician relationships, network leakage, and market-share work. Sales Enablement: Carevoyance serves MedTech targeting, prospect research, and sales-report automation.

The platform is sold by subscription across those customer markets and depends on maintaining integrated data and workflow capabilities.

Company facts

CEOKevin Coop

ListedSep 15, 2021

ExchangeNASDAQ

HeadquartersFramingham, MA

CountryUnited States

Employees686

CIK0001861795

ISINUS24477E1038

Key statistics

Market cap$84.7M

EPS (ttm)−$1.60

P/E (ttm)−0.5015

ROE-78.5%

P/B0.5869

P/S0.3639

Dividend yield—

Beta1.50vs XLV 0.09

Year to date −66.3% · Average volume (30d) 202.3K

Analysts

Price target, next 12 months$1.10+37.5%Median of 15 analysts · vs the Aug 28 close

ConsensusHold3 of 15 analysts rate it buy or better

Ratings

Strong buyBuyHoldSellStrong sell

Target range

Last close $0.8000

High$1.50+87.5%

Median$1.10+37.5%

Low$1.00+25.0%

12 months agoNowIn 12 months

Latest analyst notes

Date	Firm	Action	Prior rating	Rating	Prior target	Target
Aug 12, 2026	Deutsche Bank	Reiterate		Hold	$5	$1
Aug 11, 2026	Morgan Stanley	Reiterate		Equal Weight	$3.50	$1.50
Jun 29, 2026	Bank of America Securities	Downgrade		Positive
Jun 29, 2026	B of A Securities	Downgrade	Buy	Underperform
May 8, 2026	Robert W. Baird	Target			$4	$1.10

Earnings

EPS

Estimate$0.04

ReportedDue Nov 5, 2026

Revenue

Estimate$54.6M

ReportedDue Nov 5, 2026

History

Report date	EPS est	EPS	Surprise	Revenue est	Revenue	Surprise	Next session
Aug 10, 2026Q2 FY26	$0.04	$0.05	+17.1%	$55.5M	$55.2M	−0.5%	−7.85%
May 7, 2026Q1 FY26	$0.03	$0.06	+100.0%	$55.0M	$55.9M	+1.7%	+3.33%
Feb 26, 2026Q4 FY25	$0.06	$0.06	0.0%	$59.6M	$61.5M	+3.2%	−8.57%
Nov 6, 2025Q3 FY25	$0.06	$0.07	+16.7%	$59.6M	$60.0M	+0.8%	+10.57%

View details

Financial highlights

	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26
Revenue	$59.2M	$60.8M	$60.0M	$61.5M	$55.9M	$55.2M
Gross profit	$43.8M	$46.6M	$51.0M	$41.9M	$33.3M	$40.5M
Operating income	−$184.8M	−$4.2M	−$8.7M	$177.1M	−$4.8M	−$6.7M
Net income	−$107.2M	−$7.6M	−$14.8M	−$9.3M	−$138.6M	−$5.4M
Diluted EPS	−$0.95	−$0.07	−$0.14	−$0.09	−$1.32	−$0.05
Gross margin	73.9%	76.7%	84.9%	68.1%	59.6%	73.5%
Operating margin	-312.2%	-6.9%	-14.5%	287.7%	-8.6%	-12.2%

Fiscal years (4-quarter sums)FY21 $166.2M · FY22 $222.7M · FY23 $251.4M · FY24 $252.2M · FY25 $241.5M

Revenue by product · Q2 FY26

Subscription Services$52.8M · 96%

Professional Services$2.4M · 4%

Revenue by geography · FY25

United States$224.4M · 93%

Non-US$17.2M · 7%

Balance sheet, Jun 30, 2026Cash & short-term investments $183.6M · Total debt $167.1M · Total assets $496.8M · Shareholders' equity $144.7M

Dividends

No dividends on record.

Ownership

Institutions 84.15%88.80M sharesInsiders 10.96%11.57M sharesOther 4.89%5.15M shares

Shares outstanding 105.52M · Float 29.70M · 28.1% free float

Top shareholders13F · 13D/G · Form 4

Holder	Shares	% outstanding	Form	Filed
Advent International, L.P.	62.49M	59.82%	13G	May 14, 2026
Jason Ronald Krantz	22.16M	16.90%	13G	May 15, 2025
Goldman Sachs Group Inc	6.04M	5.73%	13F	May 15, 2026
Kevin Coop · director, officer: Chief Executive Officer	4.98M	4.71%	Form 4	Jul 6, 2026
BlackRock, Inc.	2.99M	2.83%	13F	May 13, 2026

Insider tradesForm 4

No open-market trades in the last 12 months.